Santen appoints Paolo Casati as manager of its new Italian operation

11 December 2014

Ophthalmic specialist Santen has appointed Paolo Casati as general manager of Santen Italy, following the company’s launch in the country.

He brings 30 years of management and global business leadership experience in ophthalmics, and joins the company from Alcon, where he held roles in sales and marketing departments.

Mr Casati said: "Santen group is successful thanks to its commitment to the protection and improvement of eyesight and the quality of life of patients. I am very excited to join the team to establish Santen Italy as one of major company of reference for ophthalmic world in Italy.”

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK